Information Collection

NCI/DCTD/CTEP FDA Form 1572 for Annual Submission (Attachment E01)

IC 230002 under ICR 202411-0925-001 · OMB 0925-0753.

Documents and Forms

Documents and forms in this information collection
Document Name	Document Type
Form 91 NCI/DCTD/CTEP FDA Form 1572 for Annual Submission (Attachment E01)	Form and Instruction
Form 91 CTEP FDA Form 1572 for Annual Submission NCI/DCTD/CTEP FDA Form 1572 for Annual Submission (Attachment E01)	Form and Instruction
91 CTEP FDA Form 1572 for Annual Submission PMB_Attachment_E01_CTEP_FDA_Form_1572.pdf	Form and Instruction
91 CTEP FDA Form 1572 for Annual Submission PMB_Attachment_E01_CTEP_FDA_Form_1572.pdf	Form and Instruction

IC Title:

Agency IC Tracking Number:

Is this a Common Form? No

IC Status: Unchanged

Obligation to Respond: Voluntary

CFR Citation:

Information Collection Instruments:

table that charts list of instruments
Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Form and Instruction	91				Yes	Yes	Fillable Fileable

Line of Business: Health

Subfunction: Health Care Services

Privacy Act System of Records

Title: Clinical, Basic and Population-based Research Studies of the National Institutes of Health (NIH)

FR Citation: 67 FR 60742

Number of Respondents: 26,500

Number of Respondents for Small Entity: 0

Affected Public: Private Sector

Private Sector: Businesses or other for-profits, Not-for-profit institutions

Percentage of Respondents Reporting Electronically: 100 %

table that charts list of burden
	Approved	Previously Approved
Annual Number of Responses for this IC	26,500	26,500
Annual IC Time Burden (Hours)	6,625	6,625
Annual IC Cost Burden (Dollars)	0	0

Documents for IC

table that charts IC Documents
Title	Document	Date Uploaded
No associated records found

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

Something went wrong when downloading this file. If you have any questions, please send an email to [email protected].